{
    "id": 10498,
    "fullName": "CREBBP mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CREBBP mutant indicates an unspecified mutation in the CREBBP gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 1387,
        "geneSymbol": "CREBBP",
        "terms": [
            "CREBBP",
            "CBP",
            "KAT3A",
            "MKHK1",
            "RSTS",
            "RSTS1"
        ]
    },
    "variant": "mutant",
    "createDate": "08/11/2015",
    "updateDate": "01/10/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17600,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells of a Sonic Hedgehog subtype of medulloblastoma expressing a CREBBP mutation demonstrated reduced cell proliferation in culture and decreased tumor size in mouse models when treated with Trichostatin A (TSA) (PMID: 31068675).",
            "molecularProfile": {
                "id": 10500,
                "profileName": "CREBBP mutant"
            },
            "therapy": {
                "id": 2867,
                "therapyName": "Trichostatin A",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15698,
                    "pubMedId": 31068675,
                    "title": "Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31068675"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7411,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, hematopoietic cancer cell lines harboring CREBBP mutations demonstrated sensitivity to C646 in culture and in a xenograft model, resulting in cell growth inhibition and decreased tumor growth (PMID: 26603525).",
            "molecularProfile": {
                "id": 10500,
                "profileName": "CREBBP mutant"
            },
            "therapy": {
                "id": 4483,
                "therapyName": "C646",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6332,
                    "pubMedId": 26603525,
                    "title": "Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26603525"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17599,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, small cell lung cancer cell lines harboring a CREBBP mutation demonstrated decreased cell viability when treated with Trichostatin A (TSA) in culture (PMID: 31068675).",
            "molecularProfile": {
                "id": 10500,
                "profileName": "CREBBP mutant"
            },
            "therapy": {
                "id": 2867,
                "therapyName": "Trichostatin A",
                "synonyms": null
            },
            "indication": {
                "id": 5409,
                "name": "lung small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15698,
                    "pubMedId": 31068675,
                    "title": "Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31068675"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17601,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells of a Sonic Hedgehog subtype of medulloblastoma expressing a CREBBP mutation demonstrated decreased tumor size and an extended lifespan in mouse models when treated with Farydak (panobinostat) compared to vehicle (PMID: 31068675).",
            "molecularProfile": {
                "id": 10500,
                "profileName": "CREBBP mutant"
            },
            "therapy": {
                "id": 1080,
                "therapyName": "Panobinostat",
                "synonyms": null
            },
            "indication": {
                "id": 50902,
                "name": "medulloblastoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15698,
                    "pubMedId": 31068675,
                    "title": "Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31068675"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10500,
            "profileName": "CREBBP mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}